Agile Therapeutics Inc Einnahmen
Was ist das Einnahmen von Agile Therapeutics Inc?
Einnahmen von Agile Therapeutics Inc ist 79.99%
Was ist die Definition von Einnahmen?
Das jährliche Umsatzwachstum der letzten 3 Jahre ist das durchschnittliche Umsatzwachstum der letzten 3 Jahre von einem Jahr zum nächsten.
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Einnahmen von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Agile Therapeutics Inc
Was macht Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Unternehmen mit einnahmen ähnlich Agile Therapeutics Inc
- Strong Petrochemical hat Einnahmen von 79.16%
- Donaco International hat Einnahmen von 79.29%
- Li Auto hat Einnahmen von 79.66%
- Super Micro Computer Inc hat Einnahmen von 79.79%
- China Resources Medical hat Einnahmen von 79.83%
- Kabra Extrusiontechnik hat Einnahmen von 79.97%
- Agile Therapeutics Inc hat Einnahmen von 79.99%
- MBH PLC hat Einnahmen von 80.07%
- CIT hat Einnahmen von 80.14%
- Matrix Composites & Engineering Ltd hat Einnahmen von 80.17%
- CIT Inc hat Einnahmen von 80.26%
- BCI Minerals hat Einnahmen von 80.52%
- Sprague Resources LP hat Einnahmen von 80.55%